Are Checkpoint Inhibitors Impacting How We Cure Disease?

We’re discussing Precision Medicine, and its impact on various segments of the life sciences. Steve Buckanavage, Kineticos Operating Executive, engages with Precision Biosciences’ CMO, Christopher Heery, to discuss how Precision Medicine is playing in Oncology. See below to read Steve and Chris’ discussion on how checkpoint inhibitors are impacting the potential cures for many cancers. (2019)